5.36
0.28 (5.51%)
| Penutupan Terdahulu | 5.08 |
| Buka | 5.10 |
| Jumlah Dagangan | 569,661 |
| Purata Dagangan (3B) | 703,016 |
| Modal Pasaran | 368,490,496 |
| Harga / Buku (P/B) | 2.84 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -3.14 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.91% |
| Nisbah Semasa (MRQ) | 4.95 |
| Aliran Tunai Operasi (OCF TTM) | -82.77 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -46.26 M |
| Pulangan Atas Aset (ROA TTM) | -40.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -75.45% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | PepGen Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.20 |
|
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.27% |
| % Dimiliki oleh Institusi | 95.95% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 15.00 (Oppenheimer, 179.85%) | Beli |
| Median | 11.00 (105.22%) | |
| Rendah | 7.00 (Guggenheim, 30.60%) | Beli |
| Purata | 11.00 (105.22%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 6.47 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Oppenheimer | 25 Feb 2026 | 15.00 (179.85%) | Beli | 6.40 |
| Guggenheim | 18 Feb 2026 | 7.00 (30.60%) | Beli | 6.54 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DONNELLY NOEL | 6.22 | - | 76,793 | 477,652 |
| KASRAIAN KASRA | 6.22 | - | 34,557 | 214,945 |
| MCARTHUR JAMES G | 6.22 | - | 187,688 | 1,167,419 |
| STRECK PAUL | 6.22 | - | 50,300 | 312,866 |
| VITTIGLIO JOSEPH | 6.22 | - | 30,717 | 191,060 |
| Jumlah Keseluruhan Kuantiti Bersih | 380,055 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 2,363,942 | |||
| Purata Pembelian Keseluruhan ($) | 6.22 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MCARTHUR JAMES G | Pegawai | 01 Mar 2026 | Diperolehi (+) | 187,688 | 6.22 | 1,167,419 |
| DONNELLY NOEL | Pegawai | 01 Mar 2026 | Diperolehi (+) | 76,793 | 6.22 | 477,652 |
| STRECK PAUL | Pegawai | 01 Mar 2026 | Diperolehi (+) | 50,300 | 6.22 | 312,866 |
| KASRAIAN KASRA | Pegawai | 01 Mar 2026 | Diperolehi (+) | 34,557 | 6.22 | 214,945 |
| VITTIGLIO JOSEPH | Pegawai | 01 Mar 2026 | Diperolehi (+) | 30,717 | 6.22 | 191,060 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |